NeuroPace (NPCE) Other financing activities (2020 - 2026)

NeuroPace has reported Other financing activities for 7 years, with the latest figure at $1.4 million in Q2 2026.

• On a quarterly basis, Other financing activities rose 79.77% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $2.1 million, a 18.6% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, down 2.9% from the prior year.
• Other financing activities was $1.4 million for Q2 2026 at NeuroPace, up from $10000.0 in the prior quarter.
• The five-year high for Other financing activities was $7.6 million in Q4 2023, with the low at $1000.0 in Q1 2022.
• Average Other financing activities over 5 years is $822176.5, with a median of $385000.0 recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Other financing activities plunged 99.37% in 2022, then surged 72000.0% in 2024.
• Over 5 years, Other financing activities stood at $213000.0 in 2022, then soared by 3484.04% to $7.6 million in 2023, then slumped by 92.21% to $595000.0 in 2024, then rose by 21.51% to $723000.0 in 2025, then soared by 90.46% to $1.4 million in 2026.
• The last three Other financing activities figures came in at $1.4 million (Q2 2026), $10000.0 (Q1 2026), and $723000.0 (Q4 2025), per Business Quant data.